CD8A and neoplasm: Interestingly, associated with the removal of the primary tumor by curative therapy (primary or adjuvant radiotherapy), the frequency of these HPV16-specific CD8+ T cells decreased in all patients tested in our study (Fig. 3E, lower panel).